Table 1. General characteristics of the study population.
| Parameter | Healthy (mean hepatic FF, <5%) |
Mild steatosis (mean hepatic FF, 5–14%) |
Moderate steatosis (mean hepatic FF, >14%) |
|---|---|---|---|
| No. of participants | 223 | 97 | 29 |
| Sex | |||
| Male | 195 | 51 | 13 |
| Female | 128 | 46 | 16 |
| Age, years | 58.00 (50.00, 66.00) | 57.24±12.07 | 53.00±14.28 |
| Weight, kg | 67.00 (60.00, 75.00) | 75.12±11.34 | 78.71±13.15 |
| Height, m | 1.65 (1.60, 1.74) | 1.70 (1.62, 1.75) | 1.68±0.12 |
| BMI, kg/m2 | 23.83 (21.96, 26.33) | 26.43±2.51 | 27.81±2.31 |
| ALT, U/L | 24.00 (15.00, 54.00)* | 31.00 (18.00, 46.00) | 24.00 (15.00, 36.00) |
| AST, U/L | 22.00 (18.00, 36.00)* | 21.00 (17.00, 29.00) | 22.00 (15.00, 25.00) |
| Hypertension, n (%) | 69 (30.94) | 39 (40.21) | 9 (31.03) |
| Diabetes, n (%) | 0 (0) | 27 (27.84) | 29 (100.00) |
| Antihypertensive treatment, n (%) | 68 (30.49) | 38 (39.18) | 9 (31.03) |
| Diabetes treatment, n (%) | 0 (0) | 14 (14.43) | 29 (100.00) |
| Alcohol use, n (%) | 13 (5.83) | 2 (2.06) | 1 (3.45) |
| Current smoking, n (%) | 24 (10.76) | 2 (2.06) | 2 (6.90) |
*, missing 1 participant’s data. FF, fat fraction; BMI, body mass index; ALT, alanine aminotransferase; AST, aspartate aminotransferase.